Serum vitamin B12

Overview

Serum vitamin B12 refers to the concentration of cobalamin measured in blood serum, and it is commonly used as a clinical biomarker of vitamin B12 status. Vitamin B12 is an essential water-soluble vitamin required for normal hematologic function, neurologic integrity, and one-carbon metabolism. In clinical practice, serum vitamin B12 is interpreted alongside symptoms and related laboratory markers because circulating levels do not always fully reflect tissue availability or functional deficiency.

Biologically, vitamin B12 participates in pathways linked to DNA synthesis, methylation, and homocysteine metabolism. Deficiency can contribute to megaloblastic anemia, neurologic dysfunction, and elevated homocysteine. In recent biomedical research, serum vitamin B12 has also been examined in relation to cognitive outcomes, vascular inflammation, multiple sclerosis, bariatric surgery, and outcomes in hospitalized patients with dementia, reflecting its role as both a nutritional marker and a clinically relevant exposure or target in therapeutic studies.

Focus of Latest Publications

Recent publications have investigated serum vitamin B12 in several clinical and mechanistic contexts.

In multiple sclerosis, neurotropic vitamins B1, B6, and B12 were described as being used to offer relief from immunological and neurological manifestations of the disease. One study examined how supplementation with vitamin B1/B6/B12 was associated with sphingosine-1-phosphate signaling and its receptors, with relevance to LISPR1 and APOA1-AS. This places vitamin B12 within a broader neuroimmune framework, alongside pathways implicated in immune regulation and neurologic function.

In metabolic research, vitamin B12 was included with vitamin B6 and folic acid in a control group in a trial of betaine-containing nutrients for overweight and obese patients with hyperhomocysteinemia. This reflects the common use of B12 in homocysteine-lowering nutritional regimens, where it is paired with Folate and pyridoxine to support one-carbon metabolism and potentially influence glucose-lipid metabolism.

Serum vitamin B12 has also been studied in the context of bariatric surgery. A prospective cohort study assessed serum ferritin, Folate, and vitamin B12 levels and examined their roles in weight loss after bariatric surgery. In this setting, serum vitamin B12 serves as a nutritional status marker in patients at risk of postoperative micronutrient deficiency.

A separate line of research focused on formulation science and delivery systems. One study described an effective vitamin B12 delivery system using a W/O/W double emulsion stabilized by ovalbumin and gum arabic. Although this work was centered on delivery technology rather than serum measurement, it is relevant because improving vitamin B12 stability and delivery can affect downstream serum levels and bioavailability.

Clinical deficiency states remain a major focus. A case report described pernicious anemia induced by atezolizumab in a patient with hepatocellular carcinoma and renal cell carcinoma, where the anemia was considered megaloblastic anemia induced by vitamin B12 deficiency. This underscores the importance of recognizing acquired B12 deficiency in complex oncology settings, especially when immune checkpoint therapy may be associated with hematologic complications.

Evidence synthesis has also been expanded. A Cochrane review evaluated the benefits and harms of oral vitamin B12 supplementation on vitamin B12 status, anemia, and health outcomes in women of reproductive age. This type of review is important for clarifying the clinical value of supplementation in populations where deficiency may affect maternal and hematologic health.

In neurology and aging research, vitamin B12 and Folate deficiency were identified as significant risk factors for cognitive impairment in a cohort study from the Hubei Memory and Aging Cohort Study. The study examined serum homocysteine, hemoglobin, and Alzheimer’s biomarkers in relation to Folate and vitamin B12 and their association with cognitive function. Related entities such as Beta amyloid, Serum glial fibrillary acidic protein, interleukin-6, and related dementia provide context for the broader biomarker network being explored. These findings support the view that low B12 status may contribute to cognitive decline through metabolic and neurodegenerative pathways.

Vitamin B12 has also been investigated in vascular biology. A study on dissolving microneedles for transdermal delivery of vitamin B12 reported that the approach reduced endothelial inflammation. The authors noted that vitamin B12 deficiency is a significant clinical concern, often leading to pernicious anemia and associated vascular dysfunction. This work links B12 delivery to endothelial health, with EA.hy926 endothelial cells used in the experimental framework.

Finally, serum vitamin B12 itself has been evaluated as a prognostic marker. A cohort study of hospitalized patients with dementia investigated the association between elevated serum vitamin B12 levels and All-cause mortality over 90 days. This is notable because it shifts attention from deficiency alone to the clinical meaning of high serum B12 in vulnerable hospitalized populations, where elevated levels may reflect illness severity, altered metabolism, or other underlying conditions.

Key Publications

Jun Association of vitamin B1/B6/B12 supplementation with sphingosine-1-phosphate signaling and its receptors in multiple sclerosis patients: relevance to LISPR1 and APOA1-AS. (Bioscience reports, 2026, PMID 42063363): "Neurotropic vitamins B1, B6, and B12 have been used to offer relief from immunological and neurological MS manifestations."
Jun Effects of betaine-containing nutrients on homocysteine levels and glucose-lipid metabolism in overweight and obese patients with hyperhomocysteinemia. (Nutricion hospitalaria, 2026, PMID 41960847): "or a control group (n = 50, routinely administered with vitamin B6, vitamin B12 and folic acid) using a random number table."
May The Effect of Ferritin on Weight Loss in Patients Undergoing Bariatric Surgery: A Prospective Cohort Study. (Journal of investigative surgery : the official journal of the Academy of Surgical Research, 2026, PMID 42179354): "This study aimed to assess serum ferritin, folate, and vitamin B12 levels and examine their roles in weight loss after bariatric surgery (BS)."
May Interfacial behavior and stability of ovalbumin/gum arabic complex stabilized W/O/W emulsion: fourth derivative fluorescence method. (Food chemistry, 2026, PMID 41833136): "...creating an effective vitamin B12 (VB12) delivery system."
May A Case of Pernicious Anemia Induced by Atezolizumab in Hepatocellular Carcinoma and Renal Cell Carcinoma. (The American journal of case reports, 2026, PMID 42106905): "The anemia was considered megaloblastic anemia induced by Vit.B12 deficiency (PA)."
May Vitamin B12 supplementation for anaemia, vitamin B12 status, and health outcomes in women of reproductive age. (The Cochrane database of systematic reviews, 2026, PMID 42100907): "To evaluate the benefits and harms of oral vitamin B12 supplementation on vitamin B12 status, anaemia, and health outcomes in women of reproductive age."
May Serum homocysteine, hemoglobin, and Alzheimer's biomarkers involved in the relationship of folate and vitamin B12 with cognitive function: Findings from the Hubei Memory and Aging Cohort Study. (Nutrition research (New York, N.Y.), 2026, PMID 41980534): "Vitamin B12 and folate deficiency are significant risk factors for cognitive impairment (CI), although the underlying biological mechanisms remain incompletely characterized."
May Dissolving microneedles enable effective transdermal delivery of vitamin B12 and reduce endothelial inflammation. (Journal of pharmaceutical sciences, 2026, PMID 41794175): "Vitamin B12 deficiency is a significant clinical concern, often leading to pernicious anaemia and associated vascular dysfunction."
May Serum vitamin B12 levels and 90-day outcomes in hospitalized patients with dementia: A cohort study. (Medicine, 2026, PMID 42065174): "Given the high vulnerability of this population, we aimed to investigate the association between elevated serum vitamin B12 levels and all-cause mortality."